Search research articles
Contact Us
Filters
Showing results (131-140 of 159) with videos related to
Page
of 16
Sort By:
Nature Biotechnology
|
June 10, 2022
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice
Alessio D Nahmad, Cicera R Lazzarotto, Natalie Zelikson, et al.
Science Advances
|
June 18, 2020
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
Bartek Nogal, Laura E McCoy, Marit J van Gils, et al.
Cell Reports
|
October 6, 2017
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model
James E Voss, Raiees Andrabi, Laura E McCoy, et al.
Elife
|
January 17, 2019
Reprogramming the antigen specificity of B cells using genome-editing technologies
James E Voss, Alicia Gonzalez-Martin, Raiees Andrabi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2010
gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists
Robert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 29, 2021
A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs
Deli Huang, Jenny Tuyet Tran, Linghang Peng, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2020
Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
Ge Song, Wan-Ting He, Sean Callaghan, et al.
Nature Communications
|
May 20, 2021
Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
Ge Song, Wan-Ting He, Sean Callaghan, et al.
Nature Communications
|
December 8, 2020
Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Deli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Nature Communications
|
November 18, 2020
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Deli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 159) with videos related to
Sort By:
Page
of 16
Nature Biotechnology
|
June 10, 2022
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice
Alessio D Nahmad, Cicera R Lazzarotto, Natalie Zelikson, et al.
Science Advances
|
June 18, 2020
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
Bartek Nogal, Laura E McCoy, Marit J van Gils, et al.
Cell Reports
|
October 6, 2017
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model
James E Voss, Raiees Andrabi, Laura E McCoy, et al.
Elife
|
January 17, 2019
Reprogramming the antigen specificity of B cells using genome-editing technologies
James E Voss, Alicia Gonzalez-Martin, Raiees Andrabi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2010
gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists
Robert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 29, 2021
A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs
Deli Huang, Jenny Tuyet Tran, Linghang Peng, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2020
Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
Ge Song, Wan-Ting He, Sean Callaghan, et al.
Nature Communications
|
May 20, 2021
Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
Ge Song, Wan-Ting He, Sean Callaghan, et al.
Nature Communications
|
December 8, 2020
Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Deli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Nature Communications
|
November 18, 2020
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Deli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Page
of 16